Mendly vs Youper: a tap vs an AI-guided check-in

Youper is an AI chatbot that runs daily check-ins across five therapy modalities — CBT, ACT, DBT, and more — and tracks your mood and thoughts through conversation. Mendly skips the conversation: one tap marks a thought, and a pattern builds without any back-and-forth. The difference is a guided dialogue versus a private mark.

Download on theApp Store

Free 7-day trial · then $7.99/mo or $59.99/yr

Feature comparison

MendlyYouper
Core mechanicTap to log a thought, no conversationAI chatbot conducting daily check-ins across CBT, ACT, DBT, and Problem-Solving Therapy
Clinical assessmentsNone — pattern data onlyIntegrated GAD-7 and PHQ-9 clinical assessments
Price$7.99/mo or $59.99/yr — 7-day free trialReported at $69.99/yr with no monthly option, 7-day free trial
PlatformiOS onlyiOS and Android
Time commitment per entry2-20 secondsA few minutes per chat-based check-in
Regulatory statusConsumer wellness app, not a medical deviceReceived FDA Breakthrough Device Designation in April 2026; acquired April Health in May 2026 to add a PCP-integrated escalation pathway

Who each app is for

Mendly is better for

Mendly fits people who don't want to type out a conversation every time something's on their mind, or who find a daily AI check-in starts to feel like an obligation rather than relief. If what you want is a private, wordless mark of the moment, Mendly is the lower-friction option.

Youper is better for

Youper is the better fit if you want an actual guided dialogue — someone (or something) asking follow-up questions across multiple therapy frameworks, plus built-in clinical assessments and an emerging clinical escalation pathway. Its FDA Breakthrough Device Designation signals a more clinically-oriented direction than Mendly is built for.

See the full Mendly experience: A self-criticism app your therapist can actually reference in your next session

Ready to see the difference for yourself?

Download on theApp Store

Common questions

Is Youper's FDA designation the same as FDA approval?
No. Breakthrough Device Designation, granted in April 2026, is a program that speeds up FDA review for promising devices — it isn't full market approval. It signals regulatory momentum, not a finished clinical clearance. Mendly holds no such designation and isn't positioned as a medical device.
Can Mendly replace talking to Youper's AI?
No, and it isn't trying to. Youper is built around a guided AI conversation across several clinical frameworks; Mendly is built around a one-tap log. If you specifically want something to talk to, Youper fills that need in a way Mendly deliberately doesn't.
Why doesn't Youper offer a monthly plan?
As of 2026 reporting, Youper's pricing is annual-only at roughly $69.99/year, with no monthly tier — a different structure than Mendly's flat $7.99/month or $59.99/year, which doesn't require a full-year commitment upfront.

See for yourself — 7 days free.

Try Mendly on iPhone. Cancel anytime via Apple subscriptions.

Download on theApp Store